Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Danner

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
AIDS (London, England)|August 26, 1998
Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapyG J Weverling, J M Lange, S Jurriaans, et al.
AIDS Research and Human Retroviruses|October 29, 2000
Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptationsD W Notermans, F de Wolf, P Oudshoorn, et al.
The Journal of Infectious Diseases|March 9, 1999
Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected personsF W Wit, R van Leeuwen, G J Weverling, et al.
Antiviral Therapy|August 9, 2001
A dose-ranging study to evaluate the antiretroviral activity and safety of amprenavir alone and in combination with abacavir in HIV-infected adults with limited antiretroviral experienceR T Schooley, N Clumeck, R Haubrich, et al.
Science (New York, N.Y.)|May 9, 1997
Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infectionW Cavert, D W Notermans, K Staskus, et al.
AIDS (London, England)|June 15, 2000
The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individualsR P van Heeswijk, A I Veldkamp, J W Mulder, et al.
AIDS (London, England)|February 19, 1998
Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study GroupD W Notermans, S Jurriaans, F de Wolf, et al.
The Journal of Clinical Investigation|December 31, 1997
Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectivelyA B van't Wout, L J Ran, M D de Jong, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 1998
Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infectionZ Q Zhang, D W Notermans, G Sedgewick, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 6, 2001
[HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy]M Jambroes, G J Weverling, P Reiss, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
AIDS (London, England)|August 26, 1998
Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapyG J Weverling, J M Lange, S Jurriaans, et al.
AIDS Research and Human Retroviruses|October 29, 2000
Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptationsD W Notermans, F de Wolf, P Oudshoorn, et al.
The Journal of Infectious Diseases|March 9, 1999
Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected personsF W Wit, R van Leeuwen, G J Weverling, et al.
Antiviral Therapy|August 9, 2001
A dose-ranging study to evaluate the antiretroviral activity and safety of amprenavir alone and in combination with abacavir in HIV-infected adults with limited antiretroviral experienceR T Schooley, N Clumeck, R Haubrich, et al.
Science (New York, N.Y.)|May 9, 1997
Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infectionW Cavert, D W Notermans, K Staskus, et al.
AIDS (London, England)|June 15, 2000
The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individualsR P van Heeswijk, A I Veldkamp, J W Mulder, et al.
AIDS (London, England)|February 19, 1998
Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study GroupD W Notermans, S Jurriaans, F de Wolf, et al.
The Journal of Clinical Investigation|December 31, 1997
Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectivelyA B van't Wout, L J Ran, M D de Jong, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 1998
Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infectionZ Q Zhang, D W Notermans, G Sedgewick, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 6, 2001
[HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy]M Jambroes, G J Weverling, P Reiss, et al.
Pageof 15